Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Birthmode and environment-dependent microbiota transmission dynamics are complemented by breastfeeding during the first year

  • Selma Royo, Marta
  • Dubois, Léonard
  • Manara, Serena
  • Armanini, Federica
  • Cabrera Rubio, Raúl
  • Vallès Colomer, Mireia
  • González, Sonia
  • Parra Llorca, Anna
  • Escuriet Peiró, Ramón, 1968-
  • Bode, Lars
  • Martínez Costa, Cecilia
  • Segata, Nicola
  • Collado, María Carmen
The composition and maturation of the early-life microbiota are modulated by a number of perinatal factors, whose interplay in relation to microbial vertical transmission remains inadequately elucidated. Using recent strain-tracking methodologies, we analyzed mother-to-infant microbiota transmission in two different birth environments: hospital-born (vaginal/cesarean) and home-born (vaginal) infants and their mothers. While delivery mode primarily explains initial compositional differences, place of birth impacts transmission timing-being early in homebirths and delayed in cesarean deliveries. Transmission patterns vary greatly across species and birth groups, yet certain species, like Bifidobacterium longum, are consistently vertically transmitted regardless of delivery setting. Strain-level analysis of B. longum highlights relevant and consistent subspecies replacement patterns mainly explained by breastfeeding practices, which drive changes in human milk oligosaccharide (HMO) degrading capabilities. Our findings highlight how delivery setting, breastfeeding duration, and other lifestyle preferences collectively shape vertical transmission, impacting infant gut colonization during early life., We would like to thank the Biobank (Biobanco para la Investigación Biomédica y en Salud Pública de la Comunidad Valenciana, IBSP-CV) for their work in processing the biological samples. The MAMI team would like to acknowledge the support from H2020-ERC Starting Grant (MAMI-639226 project) and from Spanish Ministry of Science and Innovation (MCIN) research grant (ref. PID2022-139475OB-I00). R.C.-R. thanks Generalitat Valenciana for the grant Plan GenT project (CDEIGENT 2020). M.C.C., M.-S.R., and R.C.-R. would also like to acknowledge the award of the Spanish Government MCIN/AEI to the Institute of Agrochemistry and Food Technology (IATA-CSIC) as Centre of Excellence Severo Ochoa (CEX2021-001189-S MCIN/AEI/10.13039/ 501100011033). This work was also supported by the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., by the European H2020 programme (ONCOBIOME-825410 project, MASTER-818368 project, and IHMCSA-964590) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S., and by EMBO ALTF 593–2020 to M.V.-C.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Paternal and induced gut microbiota seeding complement mother-to-infant transmission

  • Dubois, Léonard
  • Vallès Colomer, Mireia
  • Ponsero, Alise
  • Helve, Otto
  • Andersson, Sture
  • Kolho, Kaija-Leena
  • Asnicar, Francesco
  • Korpela, Katri
  • Salonen, Anne
  • Segata, Nicola
  • Vos, Willem M. de
Microbial colonization of the neonatal gut involves maternal seeding, which is partially disrupted in cesarean-born infants and after intrapartum antibiotic prophylaxis. However, other physically close individuals could complement such seeding. To assess the role of both parents and of induced seeding, we analyzed two longitudinal metagenomic datasets (health and early life microbiota [HELMi]: N = 74 infants, 398 samples, and SECFLOR: N = 7 infants, 35 samples) with cesarean-born infants who received maternal fecal microbiota transplantation (FMT). We found that the father constitutes a stable source of strains for the infant independently of the delivery mode, with the cumulative contribution becoming comparable to that of the mother after 1 year. Maternal FMT increased mother-infant strain sharing in cesarean-born infants, raising the average bacterial empirical growth rate while reducing pathogen colonization. Overall, our results indicate that maternal seeding is partly complemented by that of the father and support the potential of induced seeding to restore potential deviations in this process., This work was partially supported by the Netherlands Organization for Scientific Research (NWO-SIAM gravitation grant 024.002.002) to W.M.d.V., Business Finland (grant 329/31/2015) to W.M.d.V. and A.S., the Academy of Finland (grants 339172 to A.J.P. and 1325103 to A.S.), the European Research Council (ERC-StG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., and EMBO ALTF 593–2020 to M.V.-C. The work was also partially supported by the European H2020 programme (ONCOBIOME-825410 project, MASTER-818368 project, and IHMCSA-964590) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S., and by the Premio Internazionale Lombardia e Ricerca 2019 to N.S. Open access funded by the Helsinki University Library.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Intestinal Blastocystis is linked to healthier diets and more favorable cardiometabolic outcomes in 56,989 individuals from 32 countries

  • Piperni, Elisa
  • Vallès Colomer, Mireia
  • Asnicar, Francesco
Diet impacts human health, influencing body adiposity and the risk of developing cardiometabolic diseases. The gut microbiome is a key player in the diet-health axis, but while its bacterial fraction is widely studied, the role of micro-eukaryotes, including Blastocystis, is underexplored. We performed a global-scale analysis on 56,989 metagenomes and showed that human Blastocystis exhibits distinct prevalence patterns linked to geography, lifestyle, and dietary habits. Blastocystis presence defined a specific bacterial signature and was positively associated with more favorable cardiometabolic profiles and negatively with obesity (p < 1e-16) and disorders linked to altered gut ecology (p < 1e-8). In a diet intervention study involving 1,124 individuals, improvements in dietary quality were linked to weight loss and increases in Blastocystis prevalence (p = 0.003) and abundance (p < 1e-7). Our findings suggest a potentially beneficial role for Blastocystis, which may help explain personalized host responses to diet and downstream disease etiopathogenesis., We thank the participants of the PREDICT program. This work was supported by Zoe Ltd. and TwinsUK, which are funded by the Wellcome Trust, Medical Research Council, Versus Arthritis, European Union Horizon 2020, Chronic Disease Research Foundation, the National Institute for Health Research Clinical Research Network, and the Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. It was partially supported by the American Gastroenterological Association Research Foundation’s Research Scholars Award to L.H.N., the Crohn’s and Colitis Foundation Career Development Award to L.H.N., and NIH/NIDDK K23DK125838 to L.H.N. L.H.N. is the Massachusetts General Hospital/Chen Institute Transformative Scholar in Medicine. The study was supported by the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., by the European Union’s Horizon 2020 program (ONCOBIOME-825410 project, MASTER- 818368 project, and IHMCSA-964590) to N.S., by the European Union’s Horizon Europe program (DOMINO-101060218), by the European Union NextGenerationEU (INEST) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S. and R35 CA253178 to A.T.C., and by the Premio Internazionale Lombardia e Ricerca 2019 to N.S. The MBS and MLVS were supported by NIH U01CA176726 and U01CA167552. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Lifelines Biobank initiative has been made possible by the Dutch Ministry of Health, Welfare, and Sport; the Dutch Ministry of Economic Affairs; the University Medical Center Groningen; the University of Groningen; and the Northern Provinces of the Netherlands. The authors acknowledge the services of the Lifelines Cohort Study, the contributing research centers delivering data to Lifelines, and all the study participants. J.F. is supported by the Dutch Heart Foundation IN-CONTROL (CVON2018-27), the ERC-CoG (No.101001678), NWO-VICI grant VI.C.202.022, the AMMODO Science Award 2023 for Biomedical Sciences from Stichting Ammodo, and the Netherlands Organ-on-Chip Initiative, an NWO Gravitation project (024.003.001) funded by the Ministry of Education, Culture, and Science of The Netherlands. A.Z. is supported by the Dutch Heart Foundation IN-CONTROL (CVON2018-27), the ERC-StG (No. 715772), NWO-VIDI grant 016.178.056, and the NWO Gravitation grant Exposome-NL (024.004.017). A.T.C. is partially supported by an American Cancer Society Research Professor Award.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Coffee consumption is associated with intestinal Lawsonibacter asaccharolyticus abundance and prevalence across multiple cohorts

  • Manghi, Paolo
  • Vallès Colomer, Mireia
  • Song, Mingyang
Although diet is a substantial determinant of the human gut microbiome, the interplay between specific foods and microbial community structure remains poorly understood. Coffee is a habitually consumed beverage with established metabolic and health benefits. We previously found that coffee is, among >150 items, the food showing the highest correlation with microbiome components. Here we conducted a multi-cohort, multi-omic analysis of US and UK populations with detailed dietary information from a total of 22,867 participants, which we then integrated with public data from 211 cohorts (N = 54,198). The link between coffee consumption and microbiome was highly reproducible across different populations (area under the curve of 0.89), largely driven by the presence and abundance of the species Lawsonibacter asaccharolyticus. Using in vitro experiments, we show that coffee can stimulate growth of L. asaccharolyticus. Plasma metabolomics on 438 samples identified several metabolites enriched among coffee consumers, with quinic acid and its potential derivatives associated with coffee and L. asaccharolyticus. This study reveals a metabolic link between a specific gut microorganism and a specific food item, providing a framework for the understanding of microbial dietary responses at the biochemical level., This work was supported by ZOE and TwinsUK, which is funded by the Wellcome Trust, Medical Research Council, Versus Arthritis, European Union Horizon 2020, Chronic Disease Research Foundation, the National Institute for Health Research Clinical Research Network and Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. We acknowledge the support of the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., of the European Union’s Horizon 2020 programme (ONCOBIOME-825410 project, MASTER-818368 project and IHMCSA-964590) to N.S., of the MUR PNRR project INEST-Interconnected Nord-Est Innovation Ecosystem (ECS00000043) funded by the NextGenerationEU to N.S., and of the National Cancer Institute of the National Institutes of Health (1U01CA230551 to N.S. and U01CA261961 and R01CA263776 to M.S.) and of the Premio Internazionale Lombardia e Ricerca 2019 to N.S. The MBS and MLVS were supported by NIH U01CA176726 and U01CA167552. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis

  • Torres, Sandra
  • Ortiz, Cristina
  • Bachtler, Nadine
  • Gu, Wenyi
  • Grünewald, Leon D.
  • Kraus, Nico
  • Schierwagen, Robert
  • Hieber, Christoph
  • Meier, Caroline
  • Tyc, Olaf
  • Brol, Maximilian Joseph
  • Uschner, Frank Erhard
  • Nijmeijer, Bart
  • Welsch, Christoph
  • Berres, Marie-Luise
  • García-Ruiz, Carmen
  • Fernández-Checa, José C.
  • Trautwein, Christian
  • Vogl, Thomas J.
  • Zeuzem, Stefan
  • Trebicka, Jonel
  • Klein, Sabine
anus kinase 2 (JAK2) signaling is increased in human and experimental liver fibrosis with portal hypertension. JAK2 inhibitors, such as pacritinib, are already in advanced clinical development for other indications and might also be effective in liver fibrosis. Here, we investigated the antifibrotic role of the JAK2 inhibitor pacritinib on activated hepatic stellate cells (HSCs) in vitro and in two animal models of liver fibrosis in vivo., Jonel Trebicka is supported by the German Research Foundation project ID 403224013–SFB 1382 (A09); by the German Federal Ministry of Education and Research (BMBF) for the DEEP‐HCC project; by the Hessian Ministry of Higher Education, Research, and the Arts (HMWK) for the ENABLE cluster project; and by Eurostars (Grant ID 12350). The MICROB‐PREDICT (project ID 825694), DECISION (project ID 847949), GALAXY (project ID 668031), LIVERHOPE (project ID 731875), and IHMCSA (project ID 964590) projects have received funding from the European Union's Horizon 2020 research and innovation program. The manuscript reflects only the authors' views, and the European Commission is not responsible for any use that may be made of the information it contains. The funders had no influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Palmitoylcarnitine impairs immunity in decompensated cirrhosis

  • Wei Zhang, Ingrid
  • Sánchez-Rodríguez, María Belén
  • López-Vicario, Cristina
  • Casulleras, Mireia
  • Duran-Güell, Marta
  • Flores-Costa, Roger
  • Aguilar, Ferran
  • Rothe, Michael
  • Segalés, Paula
  • García-Ruiz, Carmen
  • Fernández-Checa, José C.
  • Trebicka, Jonel
  • Arroyo, Vicente
  • Clària, Joan
In patients with cirrhosis, acute decompensation (AD) correlates with a hyperinflammatory state driven by mitochondrial dysfunction, which is a significant factor in the progression toward acute-on-chronic liver failure (ACLF). Elevated circulating levels of acylcarnitine, indicative of mitochondrial dysfunction, are predictors of mortality in ACLF patients. Our hypothesis posits that acylcarnitines not only act as biomarkers, but also actively exert detrimental effects on circulating immune cells., Supported by the Plan Nacional de I+D funded by the Agencia Estatal de Investigación (grants PID2019-105240RB-I00 and PID2022-138970OB-I00 [to JC] and PID2019-111669RB-100 and PID2020-115055RB-I00 [to JCF-C]). JC laboratory is a Consolidated Research Group recognised by the Generalitat de Catalunya (2021 SGR 01323) and receives funds from EF CLIF and European Union’s Horizon 2020 research and innovation programme (MICROB-PREDICT [project ID 825694], DECISION [project ID 847949]). JCF-C receives funds from the center grant P50AA011999 Southern California Research Center for ALPD and Cirrhosis funded by NIAAA/NIH, the Project 201916/31 by Fundació Marató TV3 and the European Horizon´s research and innovation program HORIZON-HLTH-2022-STAYHLTH-02 under agreement No 101095679. JT is supported by the German Research Foundation project ID 403224013 – SFB 1382 (A09), by the German Federal Ministry of Education and Research for the DEEP-HCC project and by the Hessian Ministry of Higher Education, Research, the Arts for the ENABLE and ACLF-I cluster projects and the European Union’s Horizon 2020 research and innovation program for MICROB-PREDICT (project ID 825694), DECISION (project ID 847949), GALAXY (project ID 668031), LIVERHOPE (project ID 731875), and IHMCSA (project ID 964590) projects. IWZ was supported by the Sheila Sherlock Post Graduate Programme of the European Association for the Study of the Liver., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Diet, fruit and vegetables and One Health: benefits for health, environment, society and the consumer-proceedings of the 9th edition of EGEA conference

  • Komati, Nathalie
  • Riboli, Elio
  • Dore, Joël
  • Boyland, Emma
  • Cravedi, Jean-Pierre
  • Folkvord, Frans
  • Lecerf, Jean-Michel
  • Lescourret, Françoise
  • Peeters, Alain
  • Reynolds, Christian
  • Alles, Benjamin
  • Amiot, Marie-Josèphe
  • Binard, Philippe
  • Delzenne, Nathalie
  • Forouhi, Nita
  • Giner, Céline
  • Giyose, Boitshepo
  • Gonzalez, Carmen Gloria
  • Gunter, Marc J.
  • Kahane, Rémi
  • Herforth, Anna
  • Hermans, Roel
  • Intrigliolo, Diego S.
  • Montanaro, Giuseppe
  • Neri, Davide
  • Nicklaus, Sophie
  • Santacoloma, Pilar
  • Sauvaitre, Daniel
  • Selosse, Marc-André
  • Smits, Tim
  • Stranges, Saverio
  • Thivel, David
  • Toledo, Piedad Coscollá
  • Van Lieshout, Machteld
  • Verschuren, W. M. Monique
  • Wickramasinghe, Kremlin
  • Zeinstra, Gertrude
  • Chambrier, Claire
  • Calvarin, Johanna
  • Tailliez, Delphine
[Purpose] To present the outcomes of the EGEA Conference on the state of knowledge regarding the contribution of diets rich in fruit and vegetables (FV) to human and planetary health, commonly included in the One Health concept., [Methods] The 9th edition of EGEA Conference (20–22 September 2023, Barcelona) provided a transversal and multidisciplinary perspective on the contribution of FV to One Health, in particular to the health of individuals, society and the planet. Nearly 150 international scientists and stakeholders discussed the current state of knowledge. These proceedings are based both on a literature review and the scientific studies presented by the speakers., [Results] Scientific evidence confirms the role of FV in preventing cardiovascular diseases and type 2 diabetes; more evidence is needed on the effects and mechanisms of FV in cancer prevention. FV production and consumption helps ensure territorial cohesion and provides a denser, nutrient-rich diet with less environmental impact (except water use) than other food groups, but use of synthetic pesticides in FV production remains a challenge that could be addressed with agro-ecological solutions. Various factors influence consumer choice and behaviour towards FV consumption across the lifespan, with specific periods being more conducive to change. New research is emerging on the role of FV consumption in regulating gut microbiota and on both mental and brain health; the potential role of FV production and supply in tackling biodiversity loss and climate change; and better monitoring of FV consumption., [Conclusion] Sufficient evidence confirms the contribution of diet rich in FV to One Health, with some emerging research on this topic. Concerted actions are required towards an increased consumption of FV and a more diversified and environmentally neutral FV production., This publication was permitted in part by funding to Joël Doré from the European Union’s Horizon 2020 research and innovation programme (Grant agreement ERC-2017-AdG N◦788191-Homo.symbiosus and Grant agreement SC1-HCO-17-2020 N◦964590-IHMCSA). CG (OECD) acknowledges that the opinions expressed, and the arguments employed herein do not necessarily reflect the official views of the OECD or its member countries. GM (Unibas) acknowledges European Union Next-GenerationEU (PIANO NAZIONALE DI RIPRESA E RESILIENZA (PNRR)-MISSIONE 4 COMPONENTE 2, INVESTIMENTO 1.4-D.D. 1032 17/06/2022, CN00000022)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Birthmode and environment-dependent microbiota transmission dynamics are complemented by breastfeeding during the first year

  • Selma Royo, Marta
  • Dubois, Léonard
  • Manara, Serena
  • Armanini, Federica
  • Cabrera Rubio, Raúl
  • Vallès Colomer, Mireia
  • González, Sonia
  • Parra Llorca, Anna
  • Escuriet Peiró, Ramón, 1968-
  • Bode, Lars
  • Martínez Costa, Cecilia
  • Segata, Nicola
  • Collado, María Carmen
The composition and maturation of the early-life microbiota are modulated by a number of perinatal factors, whose interplay in relation to microbial vertical transmission remains inadequately elucidated. Using recent strain-tracking methodologies, we analyzed mother-to-infant microbiota transmission in two different birth environments: hospital-born (vaginal/cesarean) and home-born (vaginal) infants and their mothers. While delivery mode primarily explains initial compositional differences, place of birth impacts transmission timing-being early in homebirths and delayed in cesarean deliveries. Transmission patterns vary greatly across species and birth groups, yet certain species, like Bifidobacterium longum, are consistently vertically transmitted regardless of delivery setting. Strain-level analysis of B. longum highlights relevant and consistent subspecies replacement patterns mainly explained by breastfeeding practices, which drive changes in human milk oligosaccharide (HMO) degrading capabilities. Our findings highlight how delivery setting, breastfeeding duration, and other lifestyle preferences collectively shape vertical transmission, impacting infant gut colonization during early life., We would like to thank the Biobank (Biobanco para la Investigación Biomédica y en Salud Pública de la Comunidad Valenciana, IBSP-CV) for their work in processing the biological samples. The MAMI team would like to acknowledge the support from H2020-ERC Starting Grant (MAMI-639226 project) and from Spanish Ministry of Science and Innovation (MCIN) research grant (ref. PID2022-139475OB-I00). R.C.-R. thanks Generalitat Valenciana for the grant Plan GenT project (CDEIGENT 2020). M.C.C., M.-S.R., and R.C.-R. would also like to acknowledge the award of the Spanish Government MCIN/AEI to the Institute of Agrochemistry and Food Technology (IATA-CSIC) as Centre of Excellence Severo Ochoa (CEX2021-001189-S MCIN/AEI/10.13039/ 501100011033). This work was also supported by the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., by the European H2020 programme (ONCOBIOME-825410 project, MASTER-818368 project, and IHMCSA-964590) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S., and by EMBO ALTF 593–2020 to M.V.-C.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Paternal and induced gut microbiota seeding complement mother-to-infant transmission

  • Dubois, Léonard
  • Vallès Colomer, Mireia
  • Ponsero, Alise
  • Helve, Otto
  • Andersson, Sture
  • Kolho, Kaija-Leena
  • Asnicar, Francesco
  • Korpela, Katri
  • Salonen, Anne
  • Segata, Nicola
  • Vos, Willem M. de
Microbial colonization of the neonatal gut involves maternal seeding, which is partially disrupted in cesarean-born infants and after intrapartum antibiotic prophylaxis. However, other physically close individuals could complement such seeding. To assess the role of both parents and of induced seeding, we analyzed two longitudinal metagenomic datasets (health and early life microbiota [HELMi]: N = 74 infants, 398 samples, and SECFLOR: N = 7 infants, 35 samples) with cesarean-born infants who received maternal fecal microbiota transplantation (FMT). We found that the father constitutes a stable source of strains for the infant independently of the delivery mode, with the cumulative contribution becoming comparable to that of the mother after 1 year. Maternal FMT increased mother-infant strain sharing in cesarean-born infants, raising the average bacterial empirical growth rate while reducing pathogen colonization. Overall, our results indicate that maternal seeding is partly complemented by that of the father and support the potential of induced seeding to restore potential deviations in this process., This work was partially supported by the Netherlands Organization for Scientific Research (NWO-SIAM gravitation grant 024.002.002) to W.M.d.V., Business Finland (grant 329/31/2015) to W.M.d.V. and A.S., the Academy of Finland (grants 339172 to A.J.P. and 1325103 to A.S.), the European Research Council (ERC-StG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., and EMBO ALTF 593–2020 to M.V.-C. The work was also partially supported by the European H2020 programme (ONCOBIOME-825410 project, MASTER-818368 project, and IHMCSA-964590) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S., and by the Premio Internazionale Lombardia e Ricerca 2019 to N.S. Open access funded by the Helsinki University Library.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Coffee consumption is associated with intestinal Lawsonibacter asaccharolyticus abundance and prevalence across multiple cohorts

  • Manghi, Paolo
  • Vallès Colomer, Mireia
  • Song, Mingyang
Although diet is a substantial determinant of the human gut microbiome, the interplay between specific foods and microbial community structure remains poorly understood. Coffee is a habitually consumed beverage with established metabolic and health benefits. We previously found that coffee is, among >150 items, the food showing the highest correlation with microbiome components. Here we conducted a multi-cohort, multi-omic analysis of US and UK populations with detailed dietary information from a total of 22,867 participants, which we then integrated with public data from 211 cohorts (N = 54,198). The link between coffee consumption and microbiome was highly reproducible across different populations (area under the curve of 0.89), largely driven by the presence and abundance of the species Lawsonibacter asaccharolyticus. Using in vitro experiments, we show that coffee can stimulate growth of L. asaccharolyticus. Plasma metabolomics on 438 samples identified several metabolites enriched among coffee consumers, with quinic acid and its potential derivatives associated with coffee and L. asaccharolyticus. This study reveals a metabolic link between a specific gut microorganism and a specific food item, providing a framework for the understanding of microbial dietary responses at the biochemical level., This work was supported by ZOE and TwinsUK, which is funded by the Wellcome Trust, Medical Research Council, Versus Arthritis, European Union Horizon 2020, Chronic Disease Research Foundation, the National Institute for Health Research Clinical Research Network and Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. We acknowledge the support of the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., of the European Union’s Horizon 2020 programme (ONCOBIOME-825410 project, MASTER-818368 project and IHMCSA-964590) to N.S., of the MUR PNRR project INEST-Interconnected Nord-Est Innovation Ecosystem (ECS00000043) funded by the NextGenerationEU to N.S., and of the National Cancer Institute of the National Institutes of Health (1U01CA230551 to N.S. and U01CA261961 and R01CA263776 to M.S.) and of the Premio Internazionale Lombardia e Ricerca 2019 to N.S. The MBS and MLVS were supported by NIH U01CA176726 and U01CA167552. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Intestinal Blastocystis is linked to healthier diets and more favorable cardiometabolic outcomes in 56,989 individuals from 32 countries

  • Piperni, Elisa
  • Vallès Colomer, Mireia
  • Asnicar, Francesco
Diet impacts human health, influencing body adiposity and the risk of developing cardiometabolic diseases. The gut microbiome is a key player in the diet-health axis, but while its bacterial fraction is widely studied, the role of micro-eukaryotes, including Blastocystis, is underexplored. We performed a global-scale analysis on 56,989 metagenomes and showed that human Blastocystis exhibits distinct prevalence patterns linked to geography, lifestyle, and dietary habits. Blastocystis presence defined a specific bacterial signature and was positively associated with more favorable cardiometabolic profiles and negatively with obesity (p < 1e-16) and disorders linked to altered gut ecology (p < 1e-8). In a diet intervention study involving 1,124 individuals, improvements in dietary quality were linked to weight loss and increases in Blastocystis prevalence (p = 0.003) and abundance (p < 1e-7). Our findings suggest a potentially beneficial role for Blastocystis, which may help explain personalized host responses to diet and downstream disease etiopathogenesis., We thank the participants of the PREDICT program. This work was supported by Zoe Ltd. and TwinsUK, which are funded by the Wellcome Trust, Medical Research Council, Versus Arthritis, European Union Horizon 2020, Chronic Disease Research Foundation, the National Institute for Health Research Clinical Research Network, and the Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. It was partially supported by the American Gastroenterological Association Research Foundation’s Research Scholars Award to L.H.N., the Crohn’s and Colitis Foundation Career Development Award to L.H.N., and NIH/NIDDK K23DK125838 to L.H.N. L.H.N. is the Massachusetts General Hospital/Chen Institute Transformative Scholar in Medicine. The study was supported by the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., by the European Union’s Horizon 2020 program (ONCOBIOME-825410 project, MASTER- 818368 project, and IHMCSA-964590) to N.S., by the European Union’s Horizon Europe program (DOMINO-101060218), by the European Union NextGenerationEU (INEST) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S. and R35 CA253178 to A.T.C., and by the Premio Internazionale Lombardia e Ricerca 2019 to N.S. The MBS and MLVS were supported by NIH U01CA176726 and U01CA167552. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Lifelines Biobank initiative has been made possible by the Dutch Ministry of Health, Welfare, and Sport; the Dutch Ministry of Economic Affairs; the University Medical Center Groningen; the University of Groningen; and the Northern Provinces of the Netherlands. The authors acknowledge the services of the Lifelines Cohort Study, the contributing research centers delivering data to Lifelines, and all the study participants. J.F. is supported by the Dutch Heart Foundation IN-CONTROL (CVON2018-27), the ERC-CoG (No.101001678), NWO-VICI grant VI.C.202.022, the AMMODO Science Award 2023 for Biomedical Sciences from Stichting Ammodo, and the Netherlands Organ-on-Chip Initiative, an NWO Gravitation project (024.003.001) funded by the Ministry of Education, Culture, and Science of The Netherlands. A.Z. is supported by the Dutch Heart Foundation IN-CONTROL (CVON2018-27), the ERC-StG (No. 715772), NWO-VIDI grant 016.178.056, and the NWO Gravitation grant Exposome-NL (024.004.017). A.T.C. is partially supported by an American Cancer Society Research Professor Award.
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

Birthmode and environment-dependent microbiota transmission dynamics are complemented by breastfeeding during the first year

  • Selma Royo, M.
  • Dubois, L.
  • Manara, S.
  • Armanini, F.
  • Cabrera Rubio, R.
  • Valles Colomer, M.
  • González Solares, Sonia|||0000-0003-2602-7036
  • Parra Llorca, A.
  • Escuriet, R.
  • Bode, L.
  • Martínez Costa, C.
  • Segata, N.
  • Collado, M. C.
H2020-ERC Starting Grant (MAMI-639226 project) and from Spanish Ministry of Science and Innovation (MCIN) research grant (ref. PID2022-139475OB-I00). R.C.-R. thanks Generalitat Valenciana for the grant Plan GenT project (CDEIGENT 2020). M.C.C., M.-S.R., and R.C.-R. would also like to acknowledge the award of the Spanish Government MCIN/AEI to the Institute of Agrochemistry and Food Technology (IATA-CSIC) as Centre of Excellence Severo Ochoa (CEX2021-001189-S MCIN/AEI/10.13039/ 501100011033). This work was also supported by the European Research Council (ERC-STG project MetaPG716575 and ERC-CoG microTOUCH-101045015) to N.S., by the European H2020 programme (ONCOBIOME-825410 project, MASTER-818368 project, and IHMCSA-964590) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S., and by EMBO ALTF 593–2020 to M.V.-C.